Abiopharma

iRhythm Technologies, Inc. - iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference

Nuvation Bio Inc. - Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan

DexCom, Inc. - Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Agenus Inc. - France Expands National AAC Access for Agenus Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas

BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

XOMA Royalty Announces CFO Transition

Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance

Kiniksa Pharmaceuticals Provides Corporate Update